T
BMY icon

Tidemark’s Bristol-Myers Squibb BMY Stock Holding History

Tidemark’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$507K Buy
8,366
+56
+0.7% +$3.27K 0.13% 76
2025
Q4 		$448K Sell
8,310
-202
-2% -$9.72K 0.13% 77
2025
Q3 		$384K Buy
8,512
+7,214
+556% +$337K 0.11% 86
2025
Q2 		$60.1K Sell
1,298
-117
-8% -$5.74K 0.02% 218
2025
Q1 		$86.3K Sell
1,415
-648
-31% -$37.8K 0.03% 184
2024
Q4 		$117K Sell
2,063
-332
-14% -$18.6K 0.04% 159
2024
Q3 		$124K Buy
2,395
+12
+0.5% +$563 0.05% 145
2024
Q2 		$99K Buy
2,383
+843
+55% +$37.7K 0.05% 154
2024
Q1 		$83.5K Sell
1,540
-90
-6% -$4.58K 0.05% 185
2023
Q4 		$83.6K Buy
+1,630
New +$85.6K 0.05% 177

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tidemark's BMY Position: Q1 2026 in Review

Tidemark increased its Bristol-Myers Squibb (BMY) stake by 0.67% in Q1 2026, buying an estimated $3.27K and bringing the position to 8,366 shares worth $507K. The position accounts for 0.13% of the portfolio, ranked #76.

Tidemark first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tidemark held 8,366 shares of Bristol-Myers Squibb worth $507K as of Q1 2026.
  • Tidemark bought 56 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.27K.
  • Bristol-Myers Squibb made up 0.13% of Tidemark's portfolio in Q1 2026, its #76 holding.
  • Tidemark first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.